Correlation Between Inovio Pharmaceuticals and BridgeBio Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and BridgeBio Pharma, you can compare the effects of market volatilities on Inovio Pharmaceuticals and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and BridgeBio Pharma.

Diversification Opportunities for Inovio Pharmaceuticals and BridgeBio Pharma

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Inovio and BridgeBio is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and BridgeBio Pharma go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and BridgeBio Pharma

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to generate 5.7 times less return on investment than BridgeBio Pharma. In addition to that, Inovio Pharmaceuticals is 1.06 times more volatile than BridgeBio Pharma. It trades about 0.01 of its total potential returns per unit of risk. BridgeBio Pharma is currently generating about 0.05 per unit of volatility. If you would invest  1,652  in BridgeBio Pharma on September 11, 2024 and sell it today you would earn a total of  1,298  from holding BridgeBio Pharma or generate 78.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  BridgeBio Pharma

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
BridgeBio Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BridgeBio Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, BridgeBio Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Inovio Pharmaceuticals and BridgeBio Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and BridgeBio Pharma

The main advantage of trading using opposite Inovio Pharmaceuticals and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.
The idea behind Inovio Pharmaceuticals and BridgeBio Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Valuation
Check real value of public entities based on technical and fundamental data